The International Association of Infection Experts headed by the main infectious disease specialist of the Ministry of Health of Russia, Irina Shestakova, presented new 'Influenza in Adults' Federal Clinical Guidelines at the 3rd All-Russian scientific-practical conference 'Socially Significant and Especially Dangerous Infectious Diseases', which held in Sochi November 1 to 4, 2017.
Experts recommend to useRiamilovir (the proposed INN for Triazavirin) as a direct antiviral remedy in the conservative treatment of influenza.
It has a wide range of antiviral activity against RNA-containing viruses, including influenza A and B viruses and their highly pathogenic subtypes," an official source states.
In the new Federal Clinical Guidelines, drugs have been categorized by their level of effectiveness. The first group is direct antiviral remedies with proven effectiveness. In total, there are four of them, including Triazaverin. The second group is drugs with an indirect antiviral effect. For each of them, the level of evidence is provided, so this information will be helpful and interesting to doctors.
The 'Influenza in Adults' Federal Clinical Guidelines can be found here